Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000244

Options or other derivatives

  • President and CEO acquired 303,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
White Marvin L President and CEO 2020-02-18 Grant or award · Stock Option (right to buy) +303,200 303,200 D: show line 1 in the form
Loading xslF345X03/white.xml…